Myeloid Hypertensive Syndrome
Conditions
Interventions
Observational group:None
Sponsors
General Hospital of Shanxi Yangquan Coal Industry (Group) Co., Ltd.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age>=18 years old; 2.American Society of Anesthesiologists (ASA) physical status classification I–III; 3.voluntary participation in the study and signed informed consent form.
Exclusion criteria
Exclusion criteria: 1. Hypertensive encephalopathy; 2. Patients with chronic obstructive pulmonary disease (COPD); 3. Intracranial space-occupying lesions; 4. History of previous intracranial surgery; 5. Ocular diseases affecting ultrasound measurements; 6. Refusal to sign the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ONSD(Optic Nerve Sheath Diameter ); | — |
Secondary
| Measure | Time frame |
|---|---|
| The Total Volume of irrigating fluid;The Height of irrigating fluid;Duration of surgery;Other indicators (including blood pressure, heart rate, end-tidal carbon dioxide pressure, fluid intake and output, incidence of dural puncture, and postoperative neurological complications); | — |
Countries
China
Contacts
Public ContactYang Cuiying
General Hospital of Shanxi Yangquan Coal Industry (Group) Co., Ltd.
Outcome results
None listed